The presentation of Hyperfine's Swoop system at a major conference like CTAD, focusing on a critical area such as Alzheimer's research, is likely to enhance the company's reputation and investor interest. The advanced imaging capabilities could be seen as a significant innovation, potentially leading to increased demand and positive sentiment around the stock.